⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CRVO News
CervoMed Inc. Common Stock
CervoMed Announces New Data at the 2026 AAN Annual Meeting that Demonstrated Neflamapimod Increased Basal Forebrain Volume and Functional Connectivity in Dementia with Lewy Bodies
globenewswire.com
CRVO
Form 8-K
sec.gov
CRVO
CervoMed to Provide Neflamapimod Clinical Program Update and Participate in a Panel on Biomarkers at 2026 Lewy Body Dementia Association Annual Meeting
globenewswire.com
CRVO
Form 8-K
sec.gov
CRVO
Form 8-K
sec.gov
CRVO
CervoMed Announces New Data at the AD/PD™ 2026 Scientific Conference that Reinforce Neflamapimod’s Positive Effects in Dementia with Lewy Bodies (DLB) in Patients without Alzheimer’s Disease Co-Pathology
globenewswire.com
CRVO
Form 8-K
sec.gov
CRVO
CervoMed Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Updates
globenewswire.com
CRVO
CervoMed Announces Presentations at Upcoming AD/PD™ 2026 Scientific Conference
globenewswire.com
CRVO
CervoMed to Participate in Upcoming Investor Conferences
globenewswire.com
CRVO